Page 280 - Cardiac Nursing
P. 280

6
                             6
                             6
                          q
                           xd
                           xd
                              /29
                                   1
                                   1
                                   0:2
                              /29
                                /09
                                /09
                          q
                   p
                   p
                    24
                                                      c.
                                                      c.
                                                    In
                    24
                        66.
                        66.
                          q
                                                    In
                      5-2
                      5-2
                                   0:2
                                                 p
                                                  t
                                                  t
                                                A
                                                 p
                                                 p
                                                  ara
                                                   a
                                                   a
                                                   a
                                                  ara
                                                  ara
                                                   a
                                                A
                                        M
                                          Pa
                                          Pa
                                     1 P
                                     1 P
                                        M
                                           g
                                            e 2
                                              56
                                              56
                                           g
                                           g
                                            e 2
               0-c
               0-c
                 11_
                 11_
            K34
         LWB
         LWBK340-c11_ pp245-266.qxd  6/29/09  10:21 PM  Page 256 Aptara Inc.
            K34
         LWB
                  256    P A R T  III / Assessment of Heart Disease
                  pressure rises. 70  Researchers believe that ANP is released as an  also be useful in differentiating constrictive pericarditis from re-
                  acute response to increased volume in the heart, whereas BNP acts  strictive cardiomyopathy. BNP measurements should be used as
                  as a backup hormone only activated after prolonged volume  an adjunct to clinical assessment and treatment of heart failure. 76
                         69
                  overload. Both hormones act in a similar manner to increase the  See Table 11-4 for reference range.
                  loss of water and sodium through the kidneys. Renin and aldos-
                  terone are suppressed by the hormones. Glomerular filtration rate
                  is increased by renal vasculature dilation. ANP and BNP have di-  HEMATOLOGIC STUDIES
                  uretic and antihypertensive effects.
                     Although ANP and BNP both have laboratory assays available,  Cells in the circulating blood are responsible for oxygen and car-
                  BNP has emerged as the laboratory marker of choice for evaluat-  bon dioxide transport and the body’s immune response. Erythro-
                  ing dyspnea and heart failure since it is synthesized and secreted  cytes (RBCs), leukocytes (white blood cells), and platelets are
                  by the left ventricle. BNP testing is available as a rapid POCT or  formed in the bone marrow and are suspended in the plasma).
                  can be performed in a centralized laboratory. Plasma BNP con-  Blood is also the transport system for electrolytes, products of me-
                  centrations can vary with the assay used, age, sex, and body mass  tabolism, hormones, and plasma proteins. An appreciation of the
                  index. Normal values tend to increase with age and to be higher  roles of erythrocytes, leukocytes, and other hematologic parame-
                  in women than in men. BNP levels are often elevated in patients  ters is an important prerequisite to understanding deviations from
                  with renal insufficiency and renal failure whether they have heart  normal. This approach is helpful in planning care based on an as-
                  failure or not. A low BNP level in these patients may be useful to  sessment of the demands of daily living. Each of the aspects of a
                  exclude left ventricular dysfunction. Levels may also be elevated  hematologic study has meaning for patients in terms of their abil-
                  in patients with atrial fibrillation, pulmonary hypertension, and  ity to withstand the effects of a cardiac event.
                  sepsis.
                     McCullough et al. 71  determined that BNP concentrations  Complete Blood Cell Count
                  greater than 100 pg/mL had 90% sensitivity, 73% specificity,
                  and a 90% negative predictive value for diagnosing heart fail-  A complete blood cell (CBC) count is important for evaluating
                  ure. Wieczorek et al. 72  found similar results with a BNP assay  the oxygen-carrying capacity of the blood and the response of the
                  of greater than 100 pg/mL having 82% sensitivity and 99%  body to invasion by foreign cells such as bacteria. Because exces-
                  specificity for distinguishing control patients from those pa-  sive bleeding, bone marrow disease, hemolytic disorders, some
                  tients that had heart failure. Most dyspneic patients with heart  drugs, and infections can alter the number of leukocytes, erythro-
                  failure have a BNP level greater than 400 pg/mL, while values  cytes, or platelets in the blood, the CBC of the patient with car-
                  less than 100 pg/mL have a high negative predictive value to rule  diac disease is closely monitored. A baseline study can be com-
                  out heart failure as the cause of the dyspnea. Typically, BNP con-  pared with subsequent studies to evaluate bleeding, the effects of
                  centrations are being used in emergency departments to help  treatment, or the presence of infection (see Table 11-4).
                  differentiate heart failure from other causes of dyspnea. Maisel
                  et al. 70  determined that BNP levels were a more accurate tool for  Red Blood Cell Count
                  diagnosing heart failure than any historical or physical findings in  RBCs are formed in the bone marrow and constitute the majority
                  1586 patients evaluated for dyspnea in the emergency room.  of peripheral cells. They contain Hb and are responsible for trans-
                     BNP concentrations have been correlated with the New York  porting oxygen to the tissues (and carbon dioxide from tissues).
                  Heart Association Functional Classification of severity of heart  The average life span of an RBC is 120 days, after which it is re-
                  failure, as well as prognosis in heart failure. 69,70,72–74  Fonarow   moved from the blood by the liver, spleen, or bone marrow. 2
                  et al. 73  found that admission BNP levels along with elevated tro-  When the RBC count is more than 10% below the expected
                  ponin levels were independent predictors of in-hospital mortality  normal value, the patient is said to be anemic. Conditions under
                  in patients with acutely decompensated heart failure. The patients  which there are a decreased number of RBCs include cirrhosis,
                  with BNP levels greater than 840 pg/mL and increased troponin  hemorrhage, presence of prosthetic valves, renal disease, chronic
                                                                                                               2
                  were at particular risk for mortality.              illnesses, and various malignancies of the bone marrow. Anemia
                     BNP does not seem to be as useful in the in-hospital manage-  from any cause must be looked for in the patient with cardiac dis-
                                                     75
                  ment of patients with heart failure. Levitt et al. found that BNP  ease because it may precipitate angina, aggravate heart failure, or
                  levels did not correlate with invasive hemodynamic measure-  contribute to a diagnosis of subacute bacterial endocarditis.
                  ments, and did not reliably distinguish cardiogenic edema pa-  An RBC increase is seen in congenital heart disease, severe
                  tients from acute lung injury patients in the critical care setting.  chronic obstructive pulmonary disease, and polycythemia vera. It
                  Research continues to evaluate if serial BNP levels should be mon-  is falsely high in extracellular fluid deficit (volume contraction)
                  itored.                                             and falsely low with extracellular fluid excess. 2
                     A newer assay, plasma N-terminal proBNP (NT-proBNP) is  Hematocrit.  The Hct is the volume of packed RBCs found
                  more useful than BNP in diagnosing heart failure in patients who  in 100 mL of blood, expressed as a percent. As an indirect measure
                  have left ventricular dysfunction, are older, and are women NT-  of the RBC count, Hct increases and decreases with the RBC
                  proBNP tends to elevate to a greater extent in these patient groups. 76  count. Abnormalities in RBC size may alter Hct values. Normal
                                                                                                               2
                     BNP cannot be used to monitor therapy in patients being  ranges for Hct differ by sex and age group.
                  treated for heart failure with the drug nesiritide since the infusion
                  is detected as an increase in BNP; however, NT-proBNP may be  Hemoglobin.  The RBCs contain a complex protein com-
                  used to monitor nesiritide therapy. Other emerging uses of BNP  pound called hemoglobin. Hb is the oxygen-carrying protein of the
                  include as a prognostic tool in patients with acute coronary syn-  RBC and is an important component of the acid–base buffer system.
                  drome, stable angina, and chronic mitral regurgitation. It may  Insufficient amounts of Hb place a strain on the cardiovascular
   275   276   277   278   279   280   281   282   283   284   285